{
    "Trade/Device Name(s)": [
        "Lp(a) Calibrators",
        "Lp(a) Controls"
    ],
    "Submitter Information": "Biokit S.A.",
    "510(k) Number": "K132400",
    "Predicate Device Reference 510(k) Number(s)": [
        "K050487"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "November 15, 2013",
    "Summary Letter Received Date": "November 18, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1150",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Calibrator",
        "Quality Control Material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Lipoprotein (a)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": "",
    "Instrument(s)/Platform(s)": [
        "ARCHITECT c Systems",
        "ARCHITECT c8000 Clinical Chemistry System"
    ],
    "Method(s)/Technology(ies)": [
        "Turbidimetry",
        "Immunoturbidimetry"
    ],
    "Methodologies": [
        "Calibration curve establishment",
        "Quality control monitoring"
    ],
    "Submission Type(s)": [
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Biokit Lp(a) Calibrators and Controls for calibration and quality control of Lipoprotein (a) measurement using immunoturbidimetry on ARCHITECT c Systems",
    "Indications for Use Summary": "Lp(a) Calibrators are for establishing the calibration curve and Lp(a) Controls are for quantitative monitoring of Lipoprotein (a) using Quantia Lp(a) reagents by turbidimetry on ARCHITECT c Systems, for in vitro diagnostic use.",
    "fda_folder": "Clinical Chemistry"
}